Advert - Allergan – Case AUTH/3533/7/21

• Date posted
  21 June 2022
• Sanction
  Advertisement,
• Case number/s
  AUTH/3533/7/21 - Complainant v Allergan

For various social media posts which referred to unlicensed medicines and promoted Botox (botulinum toxin type a) to the public, Allergan was ruled in breach of the following clauses of the 2019 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting an unlicensed medicine

Clause 4.1 - Failing to include prescribing information

Clause 4.9 - Failing to include information about how to report adverse events

Clause 9.1 - Failing to maintain high standards

Clause 14.1 - Failing to certify promotional material

Clause 26.1 - Promoting a prescription only medicine to the public